呼出气一氧化氮与德国哮喘网重症哮喘队列疾病负担相关
该研究基于德国哮喘网(GAN)重症哮喘注册队列的1007例患者横断面数据,分析呼出气一氧化氮(FENO)与流行病学、实验室、临床、肺功能及生活质量参数和口服糖皮质激素(OCS)维持治疗需求的相关性。结果显示高FENO与慢性鼻窦炎/鼻息肉、晚发哮喘、肺功能差、哮喘控制不佳、生活质量低、频繁急性加重及需要OCS维持治疗相关。
要点
- 高FENO与慢性鼻窦炎/鼻息肉、晚发哮喘、肺功能差、控制不佳相关。
- 高FENO与生活质量低、频繁急性加重及需要OCS维持治疗相关。
- FENO是2型哮喘生物标志物,反映局部肺部炎症和ICS反应性。
核心结论
- 在重症哮喘队列中,高FENO与慢性鼻窦炎/鼻息肉、晚发哮喘、肺功能差、哮喘控制不佳、生活质量低、频繁急性加重及需要OCS维持治疗相关。
研究设计与样本
- 研究使用德国哮喘网(GAN)重症哮喘注册队列的1007例患者横断面数据,分析FENO与流行病学、实验室、临床、肺功能及生活质量参数和OCS维持治疗需求的相关性。
主要发现
- 高FENO与慢性鼻窦炎/鼻息肉、晚发哮喘、肺功能差、哮喘控制不佳、生活质量低、频繁急性加重及需要OCS维持治疗相关。
临床怎么用
- 在重症哮喘评估中,FENO可作为识别2型炎症表型的生物标志物,高FENO提示疾病负担较重且可能需要OCS维持治疗。
局限性
- 研究为横断面设计,无法确定因果关系;原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In a severe asthma cohort of 1007 patients, high FENO was associated with chronic rhinosinusitis/polyps, later asthma onset, poor lung function and asthma control, low quality of life, frequent exacerbations and the need for maintenance OCS. #GANregistry https://bit.ly/3sNrtIQ The fraction of exhaled nitric oxide (FENO) is a biomarker for type 2 asthma, reflecting the degree of local pulmonary inflammation linked to immune pathways, including interleukin (IL)-13 [1]. In clinical practice, FENO is a reliable marker for inhaled corticosteroid (ICS) responsiveness [2] and the efficacy of biological therapies, such as those targeting IL-4/IL-13 pathways [3, 4], as well as the detection of steroid nonadherence or resistance in severe asthma [2]. The prospective Severe Asthma Registry of the German Asthma Net (GAN) enrols patients with severe asthma for in-depth assessment of phenotypes, underlying mechanisms and therapeutic strategies; GAN has been approved by respective ethics committees, with all included patients having signed informed consent [5]. Prior studies of FENO either included patients with asthma of any severity [6] or did not involve a comprehensive analysis in a large cohort [7]. We therefore used cross-sectional data from GAN to determine the correlation of FENO with epidemiological, laboratory, clinical, lung function, or quality of life parameters and the need for oral corticosteroid (OCS) maintenance therapy in a carefully selected severe asthma cohort to better characterise the severe asthma subtype with high FENO values.
引用
- Bal C, Idzko M, Škrgat S, et al. Fraction of exhaled nitric oxide is associated with disease burden in the German Asthma Net severe asthma cohort. Eur Respir J. 2022. PMID: 35273030. doi:10.1183/13993003.01233-2021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。